Literature DB >> 26615614

Obesity, metabolic abnormality, and health-related quality of life by gender: a cross-sectional study in Korean adults.

Youngran Yang1, Jerald R Herting2, Jongsan Choi3.   

Abstract

PURPOSE: This study sought to compare the association between health-related quality of life (HRQoL) and four body health types by gender.
METHODS: The study included 6217 men and 8243 women over 30 years of age chosen from a population-based survey. Participants were grouped by body mass index and metabolic abnormality into four types: metabolically healthy normal weight, metabolically abnormal but normal weight (MANW), metabolically healthy obesity (MHO), and metabolically abnormal obesity (MAO). HRQoL was measured using the EQ-5D health questionnaire. The outcomes encompassed five dimensions (mobility, self-care, usual activity, pain/discomfort, and anxiety/depression), and the impaired HRQoL dichotomized by the EQ-5D preference score. Complex sample multivariate binary logistic regression analyses were conducted to adjust for sociodemographic variables, lifestyle factors, and disease comorbidity.
RESULTS: Among men, those in the MANW group presented worse conditions on all dimensions and the impaired HRQoL compared to other men. However, no significant effect remained after adjusting for relevant covariates. For women, those in the MAO group had the most adversely affected HRQoL followed by those females in the MHO group. The domain of mobility and impaired HRQoL variable of the MAO and MHO groups remained significant when controlling for all covariates in the model.
CONCLUSIONS: The MANW is the least favorable condition of HRQoL for men, suggesting that metabolic health may associate with HRQoL more than obesity for males. In women, the MAO and MHO groups had the most adversely affected HRQoL, implying that MHO is not a favorable health condition and that obesity, in general, may be strongly associated with HRQoL in women.

Entities:  

Keywords:  Body health type; Gender; Health-related quality of life; Metabolically healthy obesity (MHO)

Mesh:

Year:  2015        PMID: 26615614     DOI: 10.1007/s11136-015-1193-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  63 in total

Review 1.  Obesity-related sleepiness and fatigue: the role of the stress system and cytokines.

Authors:  Alexandros N Vgontzas; Edward O Bixler; George P Chrousos
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

2.  Quality of life and overweight: the obesity related well-being (Orwell 97) questionnaire.

Authors:  E Mannucci; V Ricca; E Barciulli; M Di Bernardo; R Travaglini; P L Cabras; C M Rotella
Journal:  Addict Behav       Date:  1999 May-Jun       Impact factor: 3.913

3.  Current issues in the identification and treatment of metabolically healthy but obese individuals.

Authors:  G Plourde; A D Karelis
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-01-12       Impact factor: 4.222

4.  Metabolic syndrome and health-related quality of life among U.S. adults.

Authors:  Earl S Ford; Chaoyang Li
Journal:  Ann Epidemiol       Date:  2008-03       Impact factor: 3.797

5.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

6.  Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

Authors:  Johan Arnlöv; Erik Ingelsson; Johan Sundström; Lars Lind
Journal:  Circulation       Date:  2009-12-28       Impact factor: 29.690

7.  Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men.

Authors:  Johan Arnlöv; Johan Sundström; Erik Ingelsson; Lars Lind
Journal:  Diabetes Care       Date:  2010-09-17       Impact factor: 19.112

Review 8.  Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review.

Authors:  Lara L Roberson; Ehimen C Aneni; Wasim Maziak; Arthur Agatston; Theodore Feldman; Maribeth Rouseff; Thinh Tran; Michael J Blaha; Raul D Santos; Andrei Sposito; Mouaz H Al-Mallah; Ron Blankstein; Matthew J Budoff; Khurram Nasir
Journal:  BMC Public Health       Date:  2014-01-08       Impact factor: 3.295

9.  Is there an increased cardiovascular risk in metabolically healthy obese individuals? Lessons from the HUNT (Nord-Trøndelag Health) study.

Authors:  Jassim Al Suwaidi
Journal:  Glob Cardiol Sci Pract       Date:  2014-06-18

10.  The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England.

Authors:  F Søltoft; M Hammer; N Kragh
Journal:  Qual Life Res       Date:  2009-10-08       Impact factor: 4.147

View more
  4 in total

1.  Mental health and quality of life in different obesity phenotypes: a systematic review.

Authors:  Behnaz Abiri; Farhad Hosseinpanah; Seyedshahab Banihashem; Seyed Ataollah Madinehzad; Majid Valizadeh
Journal:  Health Qual Life Outcomes       Date:  2022-04-19       Impact factor: 3.077

2.  Physical health-related quality of life in relation to metabolic health and obesity among men and women in Germany.

Authors:  Julia Truthmann; Gert B M Mensink; Anja Bosy-Westphal; Ulfert Hapke; Christa Scheidt-Nave; Anja Schienkiewitz
Journal:  Health Qual Life Outcomes       Date:  2017-06-10       Impact factor: 3.186

3.  EQ-5D-5L in the General German Population: Comparison and Evaluation of Three Yearly Cross-Section Surveys.

Authors:  Manuel B Huber; Peter Reitmeir; Martin Vogelmann; Reiner Leidl
Journal:  Int J Environ Res Public Health       Date:  2016-03-21       Impact factor: 3.390

4.  Which obesity phenotypes predict poor health-related quality of life in adult men and women? Tehran Lipid and Glucose Study.

Authors:  Parisa Amiri; Sara Jalali-Farahani; Marjan Rezaei; Leila Cheraghi; Farhad Hosseinpanah; Fereidoun Azizi
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.